Nanoliposome is a promising carrier of protein and peptide biomolecule for the treatment of cancer
T Kumar Giri, A Giri, T Kumar Barman… - Anti-Cancer Agents in …, 2016 - ingentaconnect.com
Nano-liposomes are the newly developed delivery systems for cancer therapy that are
finding a position particularly suitable as peptide and protein carriers. These are three …
finding a position particularly suitable as peptide and protein carriers. These are three …
Forms and methods for interferon's encapsulation
TI Ramos, CA Villacis-Aguirre, N Santiago Vispo… - Pharmaceutics, 2021 - mdpi.com
Interferons (IFNs) are cytokines involved in the immune response that act on innate and
adaptive immunity. These proteins are natural cell-signaling glycoproteins expressed in …
adaptive immunity. These proteins are natural cell-signaling glycoproteins expressed in …
Antitumor activity of IFIX, a novel interferon-inducible HIN-200 gene, in breast cancer
Y Ding, L Wang, LK Su, JA Frey, R Shao, KK Hunt… - Oncogene, 2004 - nature.com
We identified IFIX as a new member of the hematopoietic interferon (IFN)-inducible nuclear
protein with the 200-amino-acid repeat (HIN-200) family. Six different alternatively spliced …
protein with the 200-amino-acid repeat (HIN-200) family. Six different alternatively spliced …
Stat1-dependent induction of tumor necrosis factor-related apoptosis-inducing ligand and the cell-surface death signaling pathway by interferon β in human cancer …
EA Choi, H Lei, DJ Maron, JM Wilson, J Barsoum… - Cancer research, 2003 - AACR
Type I IFNs are known to inhibit tumor cell growth and stimulate the immune system.
However, little is known of the mechanism of type I IFN-induced apoptosis in human cancer …
However, little is known of the mechanism of type I IFN-induced apoptosis in human cancer …
Decreased chicken ovalbumin upstream promoter transcription factor II expression in tamoxifen-resistant breast cancer cells
KA Riggs, NS Wickramasinghe, RK Cochrum… - Cancer research, 2006 - AACR
Tamoxifen (TAM) is successfully used for the treatment and prevention of breast cancer.
However, many patients that are initially TAM responsive develop tumors that are …
However, many patients that are initially TAM responsive develop tumors that are …
AKT activation and response to interferon-β in human cancer cells
H Lei, PJ Furlong, JH Ra, D Mullins… - Cancer biology & …, 2005 - Taylor & Francis
Significant growth inhibition and induction of apoptosis by IFN-β in cancer cells including
colorectal cancer cells have been observed. We and others have previously reported the …
colorectal cancer cells have been observed. We and others have previously reported the …
Novel delivery systems for interferons
M Hamidi, A Zarrin, M Foroozesh - Critical reviews in …, 2007 - Taylor & Francis
Interferons, IFNs, are among the most widely studied and clinically used
biopharmaceuticals. Despite their invaluable therapeutic roles, the widespread use of IFNs …
biopharmaceuticals. Despite their invaluable therapeutic roles, the widespread use of IFNs …
[图书][B] Role of chicken ovalbumin upstream promoter transcription factors (COUP-TFS) in tamoxifen resistance in human breast cancer
KA Riggs - 2008 - search.proquest.com
Tamoxifen (TAM) is widely used for treatment and prevention of breast cancer. Many
patients initially benefiting from TAM therapy develop TAM-resistant (TAM-R) tumors leading …
patients initially benefiting from TAM therapy develop TAM-resistant (TAM-R) tumors leading …